

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 9.09769801 |
| 2 | vitamin A metabolic process (GO:0006776) | 8.49194576 |
| 3 | adhesion of symbiont to host cell (GO:0044650) | 7.46715147 |
| 4 | virion attachment to host cell (GO:0019062) | 7.46715147 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.62113079 |
| 6 | phospholipid efflux (GO:0033700) | 6.46568291 |
| 7 | flavonoid metabolic process (GO:0009812) | 6.42217760 |
| 8 | regulation of cholesterol esterification (GO:0010872) | 6.15575696 |
| 9 | hormone catabolic process (GO:0042447) | 6.15250647 |
| 10 | adhesion of symbiont to host (GO:0044406) | 6.13560189 |
| 11 | plasma lipoprotein particle assembly (GO:0034377) | 6.00623924 |
| 12 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.97639573 |
| 13 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.97639573 |
| 14 | actin filament depolymerization (GO:0030042) | 5.91923676 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 5.91709630 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.91709630 |
| 17 | urea metabolic process (GO:0019627) | 5.89365295 |
| 18 | cellular glucuronidation (GO:0052695) | 5.86106103 |
| 19 | regulation of triglyceride catabolic process (GO:0010896) | 5.84931079 |
| 20 | drug catabolic process (GO:0042737) | 5.76010922 |
| 21 | protein-lipid complex assembly (GO:0065005) | 5.73243973 |
| 22 | peptide hormone processing (GO:0016486) | 5.66661569 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.63211341 |
| 24 | protein carboxylation (GO:0018214) | 5.63211341 |
| 25 | uronic acid metabolic process (GO:0006063) | 5.61840251 |
| 26 | glucuronate metabolic process (GO:0019585) | 5.61840251 |
| 27 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.53590055 |
| 28 | L-phenylalanine metabolic process (GO:0006558) | 5.46285762 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.46285762 |
| 30 | lipoprotein metabolic process (GO:0042157) | 5.36926198 |
| 31 | cholesterol efflux (GO:0033344) | 5.36394482 |
| 32 | urea cycle (GO:0000050) | 5.35218168 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.32453476 |
| 34 | digestive system process (GO:0022600) | 5.31446067 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.29101323 |
| 36 | bile acid and bile salt transport (GO:0015721) | 5.23318554 |
| 37 | modified amino acid transport (GO:0072337) | 5.16666091 |
| 38 | regulation of fibrinolysis (GO:0051917) | 5.15575186 |
| 39 | peptide catabolic process (GO:0043171) | 5.15336498 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 5.13919721 |
| 41 | digestion (GO:0007586) | 5.08384446 |
| 42 | drinking behavior (GO:0042756) | 5.06252652 |
| 43 | complement activation, alternative pathway (GO:0006957) | 4.97483788 |
| 44 | ethanol oxidation (GO:0006069) | 4.92070842 |
| 45 | lipoprotein transport (GO:0042953) | 4.89937338 |
| 46 | epoxygenase P450 pathway (GO:0019373) | 4.83731939 |
| 47 | bile acid metabolic process (GO:0008206) | 4.77134790 |
| 48 | regulation of protein activation cascade (GO:2000257) | 4.73137686 |
| 49 | alkaloid metabolic process (GO:0009820) | 4.70371054 |
| 50 | glucose 6-phosphate metabolic process (GO:0051156) | 4.68668881 |
| 51 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.61569451 |
| 52 | response to hepatocyte growth factor (GO:0035728) | 4.61569451 |
| 53 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.60623545 |
| 54 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.60623545 |
| 55 | glyoxylate metabolic process (GO:0046487) | 4.59387991 |
| 56 | reverse cholesterol transport (GO:0043691) | 4.57969240 |
| 57 | regulation of complement activation (GO:0030449) | 4.49298813 |
| 58 | cholesterol transport (GO:0030301) | 4.40911172 |
| 59 | sterol transport (GO:0015918) | 4.40911172 |
| 60 | oligosaccharide catabolic process (GO:0009313) | 4.39134726 |
| 61 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.34736392 |
| 62 | cholesterol homeostasis (GO:0042632) | 4.29860602 |
| 63 | diacylglycerol metabolic process (GO:0046339) | 4.28009358 |
| 64 | sterol homeostasis (GO:0055092) | 4.24738172 |
| 65 | aromatic amino acid family catabolic process (GO:0009074) | 4.15656608 |
| 66 | regulation of bile acid biosynthetic process (GO:0070857) | 4.15555726 |
| 67 | acylglycerol homeostasis (GO:0055090) | 4.11569943 |
| 68 | triglyceride homeostasis (GO:0070328) | 4.11569943 |
| 69 | negative regulation of sterol transport (GO:0032372) | 4.11245984 |
| 70 | negative regulation of cholesterol transport (GO:0032375) | 4.11245984 |
| 71 | fibrinolysis (GO:0042730) | 4.11179216 |
| 72 | bile acid biosynthetic process (GO:0006699) | 4.06791547 |
| 73 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.03572227 |
| 74 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.03572227 |
| 75 | endocrine process (GO:0050886) | 4.03572227 |
| 76 | high-density lipoprotein particle remodeling (GO:0034375) | 4.01901635 |
| 77 | arginine metabolic process (GO:0006525) | 3.98212861 |
| 78 | oxidative demethylation (GO:0070989) | 3.91651865 |
| 79 | plasma lipoprotein particle remodeling (GO:0034369) | 3.89308542 |
| 80 | protein-lipid complex remodeling (GO:0034368) | 3.89308542 |
| 81 | macromolecular complex remodeling (GO:0034367) | 3.89308542 |
| 82 | ethanol metabolic process (GO:0006067) | 3.87400355 |
| 83 | nucleobase catabolic process (GO:0046113) | 3.85686916 |
| 84 | heme transport (GO:0015886) | 3.84812177 |
| 85 | phenylpropanoid metabolic process (GO:0009698) | 3.82748357 |
| 86 | fructose metabolic process (GO:0006000) | 3.82420999 |
| 87 | plasma lipoprotein particle organization (GO:0071827) | 3.76411991 |
| 88 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.75423584 |
| 89 | protein-lipid complex subunit organization (GO:0071825) | 3.74979241 |
| 90 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.73201835 |
| 91 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.72702743 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.71486662 |
| 93 | amino-acid betaine metabolic process (GO:0006577) | 3.65459198 |
| 94 | negative regulation of lipase activity (GO:0060192) | 3.64518104 |
| 95 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.60535407 |
| 96 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.60176993 |
| 97 | serine family amino acid catabolic process (GO:0009071) | 3.59485486 |
| 98 | negative regulation of hemostasis (GO:1900047) | 3.58406693 |
| 99 | negative regulation of blood coagulation (GO:0030195) | 3.58406693 |
| 100 | regulation of lipoprotein metabolic process (GO:0050746) | 3.54629695 |
| 101 | purine nucleotide salvage (GO:0032261) | 3.53695916 |
| 102 | complement activation, classical pathway (GO:0006958) | 3.53237675 |
| 103 | tyrosine metabolic process (GO:0006570) | 3.53034598 |
| 104 | cellular carbohydrate catabolic process (GO:0044275) | 3.52337882 |
| 105 | regulation of systemic arterial blood pressure (GO:0003073) | 3.49383581 |
| 106 | regulation of plasminogen activation (GO:0010755) | 3.46965408 |
| 107 | protein activation cascade (GO:0072376) | 3.46621208 |
| 108 | proline metabolic process (GO:0006560) | 3.43461584 |
| 109 | response to hydroperoxide (GO:0033194) | 3.42025552 |
| 110 | S-adenosylmethionine metabolic process (GO:0046500) | 3.41580961 |
| 111 | vitamin biosynthetic process (GO:0009110) | 3.40914872 |
| 112 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.40398081 |
| 113 | acute-phase response (GO:0006953) | 3.37947224 |
| 114 | drug transmembrane transport (GO:0006855) | 3.36747246 |
| 115 | regulation of guanylate cyclase activity (GO:0031282) | 3.34114350 |
| 116 | sulfate transmembrane transport (GO:1902358) | 3.32900024 |
| 117 | complement activation (GO:0006956) | 3.31269587 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.30981037 |
| 119 | omega-hydroxylase P450 pathway (GO:0097267) | 3.28857286 |
| 120 | negative regulation of coagulation (GO:0050819) | 3.28260193 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.26065859 |
| 122 | sulfur compound transport (GO:0072348) | 3.25698614 |
| 123 | NADH metabolic process (GO:0006734) | 3.22982310 |
| 124 | xenobiotic metabolic process (GO:0006805) | 3.21760242 |
| 125 | low-density lipoprotein particle remodeling (GO:0034374) | 3.21588467 |
| 126 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.21234360 |
| 127 | negative regulation of wound healing (GO:0061045) | 3.19610060 |
| 128 | thyroid hormone metabolic process (GO:0042403) | 3.19268185 |
| 129 | regulation of digestive system process (GO:0044058) | 3.18068510 |
| 130 | drug metabolic process (GO:0017144) | 3.11879603 |
| 131 | regulation of cholesterol transport (GO:0032374) | 3.11229994 |
| 132 | regulation of sterol transport (GO:0032371) | 3.11229994 |
| 133 | neutral amino acid transport (GO:0015804) | 3.08194174 |
| 134 | sulfation (GO:0051923) | 3.07842106 |
| 135 | negative regulation of digestive system process (GO:0060457) | 3.06180693 |
| 136 | response to phenylpropanoid (GO:0080184) | 3.05483380 |
| 137 | transepithelial transport (GO:0070633) | 2.98926796 |
| 138 | negative regulation of sodium ion transport (GO:0010766) | 2.95530700 |
| 139 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.95284949 |
| 140 | polyol transport (GO:0015791) | 2.94970856 |
| 141 | lipid homeostasis (GO:0055088) | 2.92431824 |
| 142 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.90720349 |
| 143 | regulation of actin nucleation (GO:0051125) | 2.89746043 |
| 144 | positive regulation of p38MAPK cascade (GO:1900745) | 2.88368291 |
| 145 | glycerol metabolic process (GO:0006071) | 2.87308265 |
| 146 | cellular anion homeostasis (GO:0030002) | 2.85668697 |
| 147 | drug transport (GO:0015893) | 2.85114079 |
| 148 | fat-soluble vitamin metabolic process (GO:0006775) | 2.85032507 |
| 149 | thrombin receptor signaling pathway (GO:0070493) | 2.76436031 |
| 150 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.76041675 |
| 151 | COPII vesicle coating (GO:0048208) | 2.75792390 |
| 152 | exogenous drug catabolic process (GO:0042738) | 2.73777098 |
| 153 | plasma lipoprotein particle clearance (GO:0034381) | 2.73644918 |
| 154 | angiotensin maturation (GO:0002003) | 14.5766351 |
| 155 | intestinal cholesterol absorption (GO:0030299) | 12.8616240 |
| 156 | intestinal absorption (GO:0050892) | 12.8135400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.69209940 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.33029467 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.36581180 |
| 4 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.29623567 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.24658914 |
| 6 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.99241954 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.86212792 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.78155985 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.66876449 |
| 10 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.65544552 |
| 11 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.64639006 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54569123 |
| 13 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.39758579 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.32780924 |
| 15 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.27882893 |
| 16 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.07734310 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.04860847 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98047053 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.85220309 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.78840946 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.78345121 |
| 22 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.69070274 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68987789 |
| 24 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.68760221 |
| 25 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.67679507 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.67122707 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.65648446 |
| 28 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63775360 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62182731 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59244572 |
| 31 | P68_20966046_ChIP-Seq_HELA_Human | 1.56937641 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.55371495 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55176344 |
| 34 | GATA2_19941826_ChIP-Seq_K562_Human | 1.54902479 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54797518 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53813850 |
| 37 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.52984293 |
| 38 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.52486278 |
| 39 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.52262954 |
| 40 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.49255994 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45148194 |
| 42 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45092601 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44013840 |
| 44 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.42852225 |
| 45 | SA1_27219007_Chip-Seq_Bcells_Human | 1.41195577 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41048012 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40479224 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39673021 |
| 49 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39659198 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39582543 |
| 51 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.38900464 |
| 52 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38303167 |
| 53 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.38166978 |
| 54 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37942460 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35777267 |
| 56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.35565731 |
| 57 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31185341 |
| 58 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.30527229 |
| 59 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.30033872 |
| 60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29948746 |
| 61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29798825 |
| 62 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.29727565 |
| 63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27438571 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27396210 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27042899 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26418634 |
| 67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25861498 |
| 68 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.25826717 |
| 69 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.25147694 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24776947 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23322252 |
| 72 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.22901738 |
| 73 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19889533 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19639834 |
| 75 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.19358471 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19191372 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17126470 |
| 78 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.16803345 |
| 79 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16277492 |
| 80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16118737 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14380694 |
| 82 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13857411 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13817798 |
| 84 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13251067 |
| 85 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.13092870 |
| 86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11989799 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11790010 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11650844 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11307901 |
| 90 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10024608 |
| 91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07874984 |
| 92 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07511183 |
| 93 | * SOX2_21211035_ChIP-Seq_LN229_Human | 1.07445711 |
| 94 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.07429477 |
| 95 | P300_27268052_Chip-Seq_Bcells_Human | 1.06673407 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05497623 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04601839 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04090801 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03016454 |
| 100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01435950 |
| 101 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01223403 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01066533 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00988503 |
| 104 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.98946441 |
| 105 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97625495 |
| 106 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.96272310 |
| 107 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96208443 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95769663 |
| 109 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.95314406 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95159271 |
| 111 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95143057 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93875850 |
| 113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93847507 |
| 114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93500916 |
| 115 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.93195987 |
| 116 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.92937529 |
| 117 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.92225225 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91522617 |
| 119 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.91125083 |
| 120 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90621652 |
| 121 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90299330 |
| 122 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90231993 |
| 123 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.87960267 |
| 124 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.87451735 |
| 125 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87367464 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86246436 |
| 127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86206283 |
| 128 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85832943 |
| 129 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.85512072 |
| 130 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.85150833 |
| 131 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.85121069 |
| 132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85058372 |
| 133 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84726835 |
| 134 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83981864 |
| 135 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83162997 |
| 136 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83000103 |
| 137 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81291715 |
| 138 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80976392 |
| 139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80289658 |
| 140 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80241052 |
| 141 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.80182419 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79984365 |
| 143 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.79857655 |
| 144 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.77402734 |
| 145 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77221325 |
| 146 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76060160 |
| 147 | TP53_16413492_ChIP-PET_HCT116_Human | 0.75429929 |
| 148 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73880432 |
| 149 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72970809 |
| 150 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.72874596 |
| 151 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.72528673 |
| 152 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71647972 |
| 153 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.71629189 |
| 154 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.67997591 |
| 155 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.67959235 |
| 156 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.67959235 |
| 157 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.67939295 |
| 158 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.67460633 |
| 159 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.66505595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001666_abnormal_nutrient_absorption | 6.50373451 |
| 2 | MP0009840_abnormal_foam_cell | 5.03514595 |
| 3 | MP0003183_abnormal_peptide_metabolism | 4.84203782 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.69046037 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.64150432 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.18165026 |
| 7 | MP0003252_abnormal_bile_duct | 3.15116642 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 3.12618116 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.07445431 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.94765283 |
| 11 | MP0003195_calcinosis | 2.84408854 |
| 12 | MP0000462_abnormal_digestive_system | 2.69945455 |
| 13 | MP0002822_catalepsy | 2.46200123 |
| 14 | MP0003868_abnormal_feces_composition | 2.41133390 |
| 15 | MP0003866_abnormal_defecation | 2.34421534 |
| 16 | MP0005084_abnormal_gallbladder_morpholo | 2.33528589 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.27689808 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.25205427 |
| 19 | MP0004147_increased_porphyrin_level | 2.01387429 |
| 20 | MP0005360_urolithiasis | 10.1263705 |
| 21 | MP0003878_abnormal_ear_physiology | 1.98517559 |
| 22 | MP0005377_hearing/vestibular/ear_phenot | 1.98517559 |
| 23 | MP0005409_darkened_coat_color | 1.89168922 |
| 24 | MP0005448_abnormal_energy_balance | 1.70469172 |
| 25 | MP0002254_reproductive_system_inflammat | 1.67209713 |
| 26 | MP0001664_abnormal_digestion | 1.63573209 |
| 27 | MP0005365_abnormal_bile_salt | 1.61179724 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.60891417 |
| 29 | MP0000538_abnormal_urinary_bladder | 1.54954702 |
| 30 | MP0000537_abnormal_urethra_morphology | 1.51442520 |
| 31 | MP0004043_abnormal_pH_regulation | 1.51007501 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.48380381 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.46004523 |
| 34 | MP0009697_abnormal_copulation | 1.45029970 |
| 35 | MP0002089_abnormal_postnatal_growth/wei | 1.44708738 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.39514072 |
| 37 | MP0005381_digestive/alimentary_phenotyp | 1.35680126 |
| 38 | MP0002796_impaired_skin_barrier | 1.30855443 |
| 39 | MP0005670_abnormal_white_adipose | 1.27991132 |
| 40 | MP0001663_abnormal_digestive_system | 1.26681969 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.25248685 |
| 42 | MP0004270_analgesia | 1.23541248 |
| 43 | MP0006054_spinal_hemorrhage | 1.23540001 |
| 44 | MP0000477_abnormal_intestine_morphology | 1.21473181 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.20916834 |
| 46 | MP0005332_abnormal_amino_acid | 1.20826412 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.13467650 |
| 48 | MP0009379_abnormal_foot_pigmentation | 1.06341328 |
| 49 | MP0001756_abnormal_urination | 1.03912906 |
| 50 | MP0001873_stomach_inflammation | 1.03095146 |
| 51 | MP0000609_abnormal_liver_physiology | 1.02278807 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.00743892 |
| 53 | MP0003718_maternal_effect | 0.97410531 |
| 54 | MP0005174_abnormal_tail_pigmentation | 0.94904084 |
| 55 | MP0001188_hyperpigmentation | 0.90486964 |
| 56 | MP0004947_skin_inflammation | 0.89892531 |
| 57 | MP0000490_abnormal_crypts_of | 0.89191150 |
| 58 | MP0005058_abnormal_lysosome_morphology | 0.87567840 |
| 59 | MP0001849_ear_inflammation | 0.87550065 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 0.87040825 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 0.86894250 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 0.86639886 |
| 63 | MP0008872_abnormal_physiological_respon | 0.86005518 |
| 64 | MP0009053_abnormal_anal_canal | 0.85493248 |
| 65 | MP0008469_abnormal_protein_level | 0.84604348 |
| 66 | MP0005266_abnormal_metabolism | 0.81110125 |
| 67 | MP0005535_abnormal_body_temperature | 0.76515432 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 0.75800773 |
| 69 | MP0000467_abnormal_esophagus_morphology | 0.75173329 |
| 70 | MP0003950_abnormal_plasma_membrane | 0.75080185 |
| 71 | MP0005501_abnormal_skin_physiology | 0.75026976 |
| 72 | MP0001661_extended_life_span | 0.74057391 |
| 73 | MP0001764_abnormal_homeostasis | 0.72367414 |
| 74 | MP0005367_renal/urinary_system_phenotyp | 0.72339175 |
| 75 | MP0000516_abnormal_urinary_system | 0.72339175 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.72337970 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.71448029 |
| 78 | MP0005166_decreased_susceptibility_to | 0.70573482 |
| 79 | MP0010678_abnormal_skin_adnexa | 0.69486491 |
| 80 | MP0000604_amyloidosis | 0.69036434 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.68795853 |
| 82 | MP0003879_abnormal_hair_cell | 0.67999264 |
| 83 | MP0002098_abnormal_vibrissa_morphology | 0.66309406 |
| 84 | MP0003283_abnormal_digestive_organ | 0.66170239 |
| 85 | MP0006138_congestive_heart_failure | 0.65518111 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.64418962 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.59928418 |
| 88 | MP0009785_altered_susceptibility_to | 0.59925695 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.59557583 |
| 90 | MP0003136_yellow_coat_color | 0.58409839 |
| 91 | MP0001845_abnormal_inflammatory_respons | 0.57548560 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56748900 |
| 93 | MP0009764_decreased_sensitivity_to | 0.56659865 |
| 94 | MP0005395_other_phenotype | 0.56255299 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.55849008 |
| 96 | MP0001765_abnormal_ion_homeostasis | 0.54598866 |
| 97 | MP0005171_absent_coat_pigmentation | 0.54502546 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.54041287 |
| 99 | MP0009115_abnormal_fat_cell | 0.52985630 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.52067366 |
| 101 | MP0000566_synostosis | 0.51924153 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.49856712 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 0.48262311 |
| 104 | MP0009763_increased_sensitivity_to | 0.48170623 |
| 105 | MP0005451_abnormal_body_composition | 0.47777015 |
| 106 | MP0004858_abnormal_nervous_system | 0.47442890 |
| 107 | MP0003329_amyloid_beta_deposits | 0.47182087 |
| 108 | MP0000427_abnormal_hair_cycle | 0.46991341 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.46605356 |
| 110 | MP0001881_abnormal_mammary_gland | 0.46339966 |
| 111 | MP0005636_abnormal_mineral_homeostasis | 0.45466660 |
| 112 | MP0001191_abnormal_skin_condition | 0.44714482 |
| 113 | MP0003953_abnormal_hormone_level | 0.43803000 |
| 114 | MP0005334_abnormal_fat_pad | 0.43787851 |
| 115 | MP0001216_abnormal_epidermal_layer | 0.43709811 |
| 116 | MP0005408_hypopigmentation | 0.43603936 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.42138599 |
| 118 | MP0005023_abnormal_wound_healing | 0.41437657 |
| 119 | MP0003436_decreased_susceptibility_to | 0.40934008 |
| 120 | MP0002971_abnormal_brown_adipose | 0.40023260 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.39615682 |
| 122 | MP0008260_abnormal_autophagy | 0.39354060 |
| 123 | MP0000249_abnormal_blood_vessel | 0.39118622 |
| 124 | MP0003385_abnormal_body_wall | 0.38619739 |
| 125 | MP0001485_abnormal_pinna_reflex | 0.38595626 |
| 126 | MP0002638_abnormal_pupillary_reflex | 0.38425278 |
| 127 | MP0008873_increased_physiological_sensi | 0.36884657 |
| 128 | MP0005083_abnormal_biliary_tract | 0.35892519 |
| 129 | MP0000579_abnormal_nail_morphology | 0.35295349 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.34977067 |
| 131 | MP0002933_joint_inflammation | 0.34468209 |
| 132 | MP0004885_abnormal_endolymph | 0.34201688 |
| 133 | MP0005025_abnormal_response_to | 0.33493045 |
| 134 | MP0000598_abnormal_liver_morphology | 0.33129836 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.31871372 |
| 136 | MP0005330_cardiomyopathy | 0.30180140 |
| 137 | MP0008874_decreased_physiological_sensi | 0.29696986 |
| 138 | MP0000003_abnormal_adipose_tissue | 0.29554128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 8.52573906 |
| 2 | Acanthocytosis (HP:0001927) | 8.42472718 |
| 3 | Ileus (HP:0002595) | 7.87910789 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.73388614 |
| 5 | Abnormality of proline metabolism (HP:0010907) | 6.51613747 |
| 6 | Hydroxyprolinuria (HP:0003080) | 6.51613747 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.38679828 |
| 8 | Deep venous thrombosis (HP:0002625) | 6.19534276 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 5.95038529 |
| 10 | Malnutrition (HP:0004395) | 5.94194101 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.60571353 |
| 12 | Complement deficiency (HP:0004431) | 5.49619631 |
| 13 | Conjugated hyperbilirubinemia (HP:0002908) | 5.41910097 |
| 14 | Joint hemorrhage (HP:0005261) | 5.12076860 |
| 15 | Widely patent fontanelles and sutures (HP:0004492) | 5.11800145 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 5.07874044 |
| 17 | Hypolipoproteinemia (HP:0010981) | 5.03019598 |
| 18 | Pigmentary retinal degeneration (HP:0001146) | 4.94744439 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 4.93972555 |
| 20 | Potter facies (HP:0002009) | 4.85079229 |
| 21 | Facial shape deformation (HP:0011334) | 4.85079229 |
| 22 | Poikilocytosis (HP:0004447) | 4.66256456 |
| 23 | Abnormality of complement system (HP:0005339) | 4.53157379 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 4.51905009 |
| 25 | Cupped ribs (HP:0000887) | 4.46787759 |
| 26 | Autoimmune hemolytic anemia (HP:0001890) | 4.39559517 |
| 27 | Fat malabsorption (HP:0002630) | 4.38733069 |
| 28 | Hemorrhage of the eye (HP:0011885) | 4.10021860 |
| 29 | Hyperglycinuria (HP:0003108) | 3.96722398 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.92969364 |
| 31 | Glomerulonephritis (HP:0000099) | 3.90437548 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.90420121 |
| 33 | Chronic diarrhea (HP:0002028) | 3.81529549 |
| 34 | Xanthomatosis (HP:0000991) | 3.78860662 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.70362629 |
| 36 | Increased IgE level (HP:0003212) | 3.51008259 |
| 37 | Mesangial abnormality (HP:0001966) | 3.45137784 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.40945145 |
| 39 | Abdominal distention (HP:0003270) | 3.38515092 |
| 40 | Wide cranial sutures (HP:0010537) | 3.28329337 |
| 41 | Glycosuria (HP:0003076) | 3.17315530 |
| 42 | Abnormality of urine glucose concentration (HP:0011016) | 3.17315530 |
| 43 | Abnormal glucose tolerance (HP:0001952) | 3.10361481 |
| 44 | Dehydration (HP:0001944) | 3.08300617 |
| 45 | Epidermoid cyst (HP:0200040) | 3.06560677 |
| 46 | Hyperammonemia (HP:0001987) | 3.05088090 |
| 47 | Steatorrhea (HP:0002570) | 3.04359108 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.99280996 |
| 49 | Nephrolithiasis (HP:0000787) | 2.96346732 |
| 50 | Gastrointestinal dysmotility (HP:0002579) | 2.93212828 |
| 51 | B lymphocytopenia (HP:0010976) | 2.91871431 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.91871431 |
| 53 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.86021529 |
| 54 | Rickets (HP:0002748) | 2.84642885 |
| 55 | Nephritis (HP:0000123) | 2.80846446 |
| 56 | Reticulocytosis (HP:0001923) | 2.79536141 |
| 57 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.77167090 |
| 58 | Severe combined immunodeficiency (HP:0004430) | 2.75860661 |
| 59 | Increased mean platelet volume (HP:0011877) | 2.74741128 |
| 60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.72716189 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 2.72716189 |
| 62 | Hypophosphatemic rickets (HP:0004912) | 2.72707680 |
| 63 | Abnormality of vitamin B metabolism (HP:0004340) | 2.66455187 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 2.63692110 |
| 65 | Spontaneous abortion (HP:0005268) | 2.62823500 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.61865620 |
| 67 | Vaginal fistula (HP:0004320) | 2.57791837 |
| 68 | Polycythemia (HP:0001901) | 2.54944939 |
| 69 | Thyroiditis (HP:0100646) | 2.47051517 |
| 70 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.46836719 |
| 71 | Confusion (HP:0001289) | 2.46783165 |
| 72 | Combined immunodeficiency (HP:0005387) | 2.46721111 |
| 73 | Vascular calcification (HP:0004934) | 2.45716635 |
| 74 | Abnormal platelet volume (HP:0011876) | 2.41651951 |
| 75 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.41221799 |
| 76 | Hyperglycinemia (HP:0002154) | 2.39406895 |
| 77 | Intrahepatic cholestasis (HP:0001406) | 2.37436233 |
| 78 | Metabolic acidosis (HP:0001942) | 2.36923182 |
| 79 | Progressive sensorineural hearing impairment (HP:0000408) | 2.31401823 |
| 80 | Hyperphosphaturia (HP:0003109) | 2.29189515 |
| 81 | Abnormality of vitamin metabolism (HP:0100508) | 2.28568582 |
| 82 | Alkalosis (HP:0001948) | 2.25049182 |
| 83 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21320179 |
| 84 | Megaloblastic anemia (HP:0001889) | 2.18784318 |
| 85 | Abnormality of the gastric mucosa (HP:0004295) | 2.18370142 |
| 86 | Delayed epiphyseal ossification (HP:0002663) | 2.17363927 |
| 87 | Abnormality of nucleobase metabolism (HP:0010932) | 2.16241673 |
| 88 | Proximal tubulopathy (HP:0000114) | 2.14956568 |
| 89 | Cardiovascular calcification (HP:0011915) | 2.11203289 |
| 90 | Myopathic facies (HP:0002058) | 2.10154686 |
| 91 | Irritability (HP:0000737) | 2.09323184 |
| 92 | Abnormality of serum amino acid levels (HP:0003112) | 2.05403011 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04433878 |
| 94 | Progressive hearing impairment (HP:0001730) | 2.02190986 |
| 95 | Villous atrophy (HP:0011473) | 1.99769426 |
| 96 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.99769426 |
| 97 | Alopecia of scalp (HP:0002293) | 1.99687850 |
| 98 | Amyloidosis (HP:0011034) | 1.97537029 |
| 99 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96522565 |
| 100 | Neonatal onset (HP:0003623) | 1.96250955 |
| 101 | Flat acetabular roof (HP:0003180) | 1.95949159 |
| 102 | Delayed CNS myelination (HP:0002188) | 1.95803470 |
| 103 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.95712694 |
| 104 | Abnormal urine phosphate concentration (HP:0012599) | 1.94564524 |
| 105 | Milia (HP:0001056) | 1.94351376 |
| 106 | Abnormal gallbladder physiology (HP:0012438) | 1.93882686 |
| 107 | Cholecystitis (HP:0001082) | 1.93882686 |
| 108 | Elevated alkaline phosphatase (HP:0003155) | 1.93043647 |
| 109 | Increased purine levels (HP:0004368) | 1.92563266 |
| 110 | Hyperuricemia (HP:0002149) | 1.92563266 |
| 111 | Palpitations (HP:0001962) | 1.91707796 |
| 112 | Purpura (HP:0000979) | 1.89012764 |
| 113 | Gingival bleeding (HP:0000225) | 1.87539324 |
| 114 | Abnormality of eosinophils (HP:0001879) | 1.86733250 |
| 115 | Renal tubular dysfunction (HP:0000124) | 1.86070951 |
| 116 | Enlarged epiphyses (HP:0010580) | 1.85995030 |
| 117 | Thin bony cortex (HP:0002753) | 1.85942832 |
| 118 | Symptomatic seizures (HP:0011145) | 1.85057844 |
| 119 | Abnormal albumin level (HP:0012116) | 1.83112520 |
| 120 | Hypoalbuminemia (HP:0003073) | 1.83112520 |
| 121 | Woolly hair (HP:0002224) | 1.82496703 |
| 122 | Abnormality of the costochondral junction (HP:0000919) | 1.82283270 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.81766581 |
| 124 | Pili torti (HP:0003777) | 1.80805544 |
| 125 | Nausea (HP:0002018) | 1.80792524 |
| 126 | Hyperbilirubinemia (HP:0002904) | 1.80405982 |
| 127 | Mitral stenosis (HP:0001718) | 1.79398992 |
| 128 | Gout (HP:0001997) | 1.78843579 |
| 129 | Hyperparathyroidism (HP:0000843) | 1.78538777 |
| 130 | Cerebral palsy (HP:0100021) | 1.77782288 |
| 131 | Menorrhagia (HP:0000132) | 1.77409956 |
| 132 | Abnormal biliary tract morphology (HP:0012440) | 1.76596828 |
| 133 | Skin nodule (HP:0200036) | 1.76164592 |
| 134 | Hepatocellular carcinoma (HP:0001402) | 1.75614346 |
| 135 | Abnormality of methionine metabolism (HP:0010901) | 1.75161584 |
| 136 | Thrombophlebitis (HP:0004418) | 1.74813152 |
| 137 | Hypoalphalipoproteinemia (HP:0003233) | 1.74729918 |
| 138 | Gingivitis (HP:0000230) | 1.74630891 |
| 139 | Abnormal platelet function (HP:0011869) | 1.73404531 |
| 140 | Impaired platelet aggregation (HP:0003540) | 1.73404531 |
| 141 | Hypoproteinemia (HP:0003075) | 1.73322208 |
| 142 | Ulnar bowing (HP:0003031) | 1.72870326 |
| 143 | Hypophosphatemia (HP:0002148) | 1.72268462 |
| 144 | Decreased central vision (HP:0007663) | 1.71639405 |
| 145 | Syncope (HP:0001279) | 1.71524928 |
| 146 | Hypotension (HP:0002615) | 1.69393265 |
| 147 | Eosinophilia (HP:0001880) | 1.67851321 |
| 148 | Lethargy (HP:0001254) | 1.67793531 |
| 149 | Peripheral demyelination (HP:0011096) | 1.67190011 |
| 150 | Pancreatitis (HP:0001733) | 1.65890972 |
| 151 | Polygenic inheritance (HP:0010982) | 1.65701056 |
| 152 | Pustule (HP:0200039) | 1.64755746 |
| 153 | Congenital sensorineural hearing impairment (HP:0008527) | 1.63477525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 6.57395583 |
| 2 | ACVR1B | 5.96835072 |
| 3 | FRK | 5.96065184 |
| 4 | AKT3 | 4.24216891 |
| 5 | GRK6 | 4.20472322 |
| 6 | MST1R | 3.78230409 |
| 7 | NME1 | 3.41279672 |
| 8 | LMTK2 | 3.32107652 |
| 9 | MAPK15 | 3.20012361 |
| 10 | PRKG2 | 3.10581350 |
| 11 | MAP3K10 | 3.04213649 |
| 12 | EPHA2 | 2.99033777 |
| 13 | RIPK1 | 2.59145348 |
| 14 | MUSK | 2.28099729 |
| 15 | WNK4 | 2.28093885 |
| 16 | MAP3K2 | 2.25570662 |
| 17 | ERN1 | 2.20083433 |
| 18 | PTK6 | 2.07461211 |
| 19 | NUAK1 | 2.05945888 |
| 20 | PIK3CG | 2.05530652 |
| 21 | MAP2K2 | 1.84294450 |
| 22 | STK10 | 1.83948255 |
| 23 | TESK2 | 1.73401649 |
| 24 | EPHB2 | 1.49433869 |
| 25 | MET | 1.42075395 |
| 26 | EPHA4 | 1.40931764 |
| 27 | FGFR3 | 1.38563731 |
| 28 | TAOK1 | 1.33519433 |
| 29 | KDR | 1.24840062 |
| 30 | BMX | 1.23667369 |
| 31 | TESK1 | 1.20192887 |
| 32 | DDR2 | 1.18466786 |
| 33 | BCKDK | 1.17933979 |
| 34 | STK39 | 1.10765166 |
| 35 | EPHB1 | 1.10000698 |
| 36 | PRKCI | 1.06183047 |
| 37 | RIPK4 | 1.03074646 |
| 38 | EPHA3 | 1.00072209 |
| 39 | MATK | 0.99329731 |
| 40 | MAP3K8 | 0.98221591 |
| 41 | MAP3K7 | 0.96541929 |
| 42 | KSR2 | 0.94801055 |
| 43 | TRIB3 | 0.93001515 |
| 44 | ZAP70 | 0.92116529 |
| 45 | BLK | 0.90722779 |
| 46 | SIK1 | 0.90622980 |
| 47 | CSF1R | 0.87857910 |
| 48 | PTK2 | 0.85704784 |
| 49 | LATS1 | 0.85317159 |
| 50 | PRKD2 | 0.84750638 |
| 51 | FER | 0.81101609 |
| 52 | TBK1 | 0.80305775 |
| 53 | CDK4 | 0.78812439 |
| 54 | MAP3K11 | 0.77617149 |
| 55 | PRKAA2 | 0.76873858 |
| 56 | TLK1 | 0.76675337 |
| 57 | SCYL2 | 0.73571321 |
| 58 | OXSR1 | 0.73084197 |
| 59 | MELK | 0.71562367 |
| 60 | MYLK | 0.71028152 |
| 61 | ERBB2 | 0.70425124 |
| 62 | CDK8 | 0.68354193 |
| 63 | TAOK3 | 0.66862419 |
| 64 | MAP2K6 | 0.65731325 |
| 65 | PAK4 | 0.65560147 |
| 66 | SYK | 0.63938998 |
| 67 | TNIK | 0.63819994 |
| 68 | LRRK2 | 0.63679810 |
| 69 | MAP3K9 | 0.63444233 |
| 70 | ICK | 0.62148775 |
| 71 | TTK | 0.59653858 |
| 72 | MAP3K1 | 0.58596173 |
| 73 | PRPF4B | 0.57016121 |
| 74 | NLK | 0.53552291 |
| 75 | MAP2K1 | 0.53485339 |
| 76 | PDPK1 | 0.50477752 |
| 77 | TEC | 0.49644565 |
| 78 | DAPK2 | 0.48746085 |
| 79 | MAP3K3 | 0.46952617 |
| 80 | CDK12 | 0.45974288 |
| 81 | PRKACA | 0.44672347 |
| 82 | MAPK11 | 0.44384614 |
| 83 | PAK3 | 0.41242116 |
| 84 | IGF1R | 0.40629900 |
| 85 | TYK2 | 0.40251924 |
| 86 | IKBKE | 0.40027094 |
| 87 | STK16 | 0.38527073 |
| 88 | STK38 | 0.38309279 |
| 89 | PBK | 0.38127739 |
| 90 | BTK | 0.36607808 |
| 91 | CDC42BPA | 0.36035197 |
| 92 | DYRK1B | 0.35612399 |
| 93 | MAP4K1 | 0.33677873 |
| 94 | PIK3CA | 0.33556600 |
| 95 | DMPK | 0.33320391 |
| 96 | CSK | 0.33245388 |
| 97 | TYRO3 | 0.33217914 |
| 98 | PIM1 | 0.32142934 |
| 99 | LYN | 0.31454446 |
| 100 | LIMK1 | 0.31425927 |
| 101 | PRKCQ | 0.31341964 |
| 102 | PDK1 | 0.31327093 |
| 103 | SRC | 0.31306294 |
| 104 | FGR | 0.30447829 |
| 105 | PRKG1 | 0.29953738 |
| 106 | MAP3K12 | 0.29748247 |
| 107 | AKT2 | 0.29671084 |
| 108 | PRKAA1 | 0.29619292 |
| 109 | PRKCA | 0.29556798 |
| 110 | PDK2 | 0.28512256 |
| 111 | PIM2 | 0.28361013 |
| 112 | PAK2 | 0.28325440 |
| 113 | MAPKAPK2 | 0.27710534 |
| 114 | PDGFRA | 0.26831805 |
| 115 | JAK1 | 0.26586621 |
| 116 | FYN | 0.25079450 |
| 117 | ABL2 | 0.24945345 |
| 118 | ITK | 0.24904834 |
| 119 | IRAK3 | 0.23874612 |
| 120 | CSNK1A1 | 0.21749527 |
| 121 | PRKCB | 0.21596335 |
| 122 | PRKACG | 0.21439608 |
| 123 | STK3 | 0.21343581 |
| 124 | PRKCD | 0.20982834 |
| 125 | ADRBK2 | 0.20812566 |
| 126 | CDK5 | 0.20728853 |
| 127 | STK11 | 0.20559301 |
| 128 | ROCK1 | 0.20268106 |
| 129 | PRKD3 | 0.19880652 |
| 130 | PRKD1 | 0.19757475 |
| 131 | MAP2K4 | 0.19619636 |
| 132 | CDK6 | 0.18629503 |
| 133 | ERBB4 | 0.15332063 |
| 134 | PAK1 | 0.14926209 |
| 135 | GRK1 | 0.14901626 |
| 136 | GSK3A | 0.11163052 |
| 137 | MAPK4 | 0.11113478 |
| 138 | CAMK2D | 0.09370833 |
| 139 | PRKCZ | 0.06099309 |
| 140 | ROCK2 | 0.05966035 |
| 141 | FGFR4 | 0.05954287 |
| 142 | EGFR | 0.05933225 |
| 143 | JAK2 | 0.05897261 |
| 144 | RET | 0.05214747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.39921776 |
| 2 | Renin-angiotensin system_Homo sapiens_hsa04614 | 5.73048143 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.90325293 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.47263507 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 3.77051929 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.46860792 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 3.29025042 |
| 8 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 3.23912869 |
| 9 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.94416927 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.82623762 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.77875362 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54756141 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.51182236 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.01698976 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95518928 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 1.89093371 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.86763468 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.85857769 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.79968167 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.76558878 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60741793 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53991142 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.51970270 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48566937 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29292162 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.28682776 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.27309418 |
| 28 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25098282 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23909214 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22055612 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12171371 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09837357 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04291476 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03912958 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03670721 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90355747 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86222543 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84433570 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83260589 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83092878 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81525818 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80975491 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80192265 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 0.78257185 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.77863260 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76853413 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71902643 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68981951 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67484345 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65120189 |
| 51 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64479288 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62120119 |
| 53 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61301310 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58514087 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56752911 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56579537 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55930094 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53118044 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51707712 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50165098 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46556866 |
| 62 | Tight junction_Homo sapiens_hsa04530 | 0.45866133 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43695308 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42318843 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42024893 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39615760 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.38904891 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38035722 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.37157928 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35499338 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34882827 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33527048 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32988824 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30722415 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.30142382 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27140028 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.26224120 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.26040204 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24794123 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24620437 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22724234 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22509698 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.22408547 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21166072 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.20527845 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20348156 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19681599 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.19462246 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.19233632 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.18964009 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.18099901 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17971784 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.17803947 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17658077 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17429623 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.17380814 |
| 97 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.17042836 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | 0.16931826 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16818484 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16063661 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.15273400 |
| 102 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.15076700 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.14168652 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14117741 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.14019544 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.13818831 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.12916090 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12495274 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.12103795 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.11421511 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.07295559 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07151464 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.05914554 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.04965484 |
| 115 | Gap junction_Homo sapiens_hsa04540 | 0.04337324 |
| 116 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.04272683 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.03881348 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.03838362 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.02997466 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.02516823 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.01759745 |
| 122 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.01458640 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.01371152 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00475193 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00266149 |
| 126 | Cocaine addiction_Homo sapiens_hsa05030 | -0.1264543 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0830793 |
| 128 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0643896 |
| 129 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.0503949 |
| 130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | -0.0141736 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0018482 |

